UAS regulatory sequences drive expression of Act57B carrying an amino acid substitution equivalent to a variant that has been reported to be associated with hypertrophic cardiomyopathy when mutated in the human ACTC1 ortholog. (FlyBase curator comment: the mutation in the Act57B gene is given as A295S in FBrf0236636, however analysis of the release 6.32 annotated gene model indicates the change to be A296S).
G20945689T
A296S | Act57B-PA
Analogous A297S mutation in human ACTC1 implicated in cardiomyopathy, familial hypertrophic 11; mutation carried on in vitro construct.
The expression of Act57BA295S.Scer\UAS under the control of Scer\GAL4Hand.PU leads to significant decreases in cardiac output, diastolic diameter and systolic diameter, leads to a significant increase in systolic interval to the heart period heart period, but does not lead to any significant changes in heart period, as compared to controls.